McKesson (MCK) Stock Forecast & Price Target

Compare

2,203 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

MCK Analyst Ratings

Strong Buy

9 Buy

2 Hold

0 Sell

Based on 11 analysts giving stock ratings to

McKesson

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

MCK Stock 12 Month Forecast

Average Price Target

$982.27

▲(3.78% Upside)

Based on 11 Wall Street analysts offering 12 month price targets for McKesson in the last 3 months. The average price target is $982.27 with a high forecast of $1,107.00 and a low forecast of $885.00. The average price target represents a 3.78% change from the last price of $946.47.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"591":"$591","1108":"$1,108","720.25":"$720.3","849.5":"$849.5","978.75":"$978.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1107,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.11K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":982.27,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$982.27</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":885,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$885.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[591,720.25,849.5,978.75,1108],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,846.51,866.5476923076923,886.5853846153846,906.623076923077,926.6607692307692,946.6984615384615,966.7361538461538,986.7738461538461,1006.8115384615385,1026.8492307692309,1046.886923076923,1066.9246153846154,1086.9623076923076,{"y":1107,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,846.51,856.9530769230769,867.3961538461539,877.8392307692308,888.2823076923077,898.7253846153847,909.1684615384615,919.6115384615384,930.0546153846153,940.4976923076923,950.9407692307692,961.3838461538462,971.8269230769231,{"y":982.27,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,846.51,849.4707692307692,852.4315384615385,855.3923076923077,858.353076923077,861.3138461538462,864.2746153846153,867.2353846153846,870.1961538461538,873.156923076923,876.1176923076923,879.0784615384615,882.0392307692308,{"y":885,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":592.243,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":637.562,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":671.595,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":704.573,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":720.217,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":726.194,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":697.315,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":685.181,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":764.368,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":810.584,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":856.89,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":820.29,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":846.51,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$1,107

Average Price Target$982.27

Lowest Price Target$885.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Glen Santangelo

Barclays

$960→$1,050

Buy

10.94%

Upside

Reiterated

02/18/26

Barclays Keeps Their Buy Rating on McKesson (MCK)

Lisa Gill

J.P. Morgan

$983→$1,107

Buy

16.96%

Upside

Reiterated

02/10/26

McKesson price target raised to $1,107 from $983 at JPMorganMcKesson price target raised to $1,107 from $983 at JPMorgan

Steven Valiquette

Mizuho Securities

$885

Hold

-6.49%

Downside

Reiterated

02/10/26

Mizuho Securities Sticks to Its Hold Rating for McKesson (MCK)

Kevin Caliendo

UBS

$980→$1,012

Buy

6.92%

Upside

Reiterated

02/06/26

Analysts Offer Insights on Healthcare Companies: McKesson (NYSE: MCK) and Biogen (NASDAQ: BIIB)

Allen Lutz

Bank of America Securities

$950→$970

Buy

2.49%

Upside

Reiterated

02/05/26

Analysts Conflicted on These Healthcare Names: Phibro Animal Health (NASDAQ: PAHC), McKesson (NYSE: MCK) and Boston Scientific (NYSE: BSX)

Eric Coldwell

Robert W. Baird

$968→$974

Buy

2.91%

Upside

Reiterated

02/05/26

McKesson price target raised to $974 from $968 at BairdMcKesson price target raised to $974 from $968 at Baird

Charles Rhyee

TD Cowen

$1,000→$1,012

Buy

6.92%

Upside

Reiterated

02/05/26

Analysts Offer Insights on Healthcare Companies: McKesson (NYSE: MCK), GE Healthcare Technologies Inc (NASDAQ: GEHC) and Merck & Company (NYSE: MRK)

Stephen Baxter

Wells Fargo

$914→$925

Hold

-2.27%

Downside

Reiterated

02/05/26

Analysts Conflicted on These Healthcare Names: Eli Lilly & Co (NYSE: LLY), McKesson (NYSE: MCK) and Boston Scientific (NYSE: BSX)

Elizabeth Anderson CFA

Evercore ISI

$1,000

Buy

5.66%

Upside

Reiterated

02/05/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Prestige Consumer Healthcare (NYSE: PBH), McKesson (NYSE: MCK) and Bristol-Myers Squibb (NYSE: BMY)

Erin Wright

Morgan Stanley

$916→$966

Buy

2.06%

Upside

Reiterated

01/29/26

McKesson price target raised to $966 from $916 at Morgan StanleyMcKesson price target raised to $966 from $916 at Morgan Stanley

George Hill

Deutsche Bank

$861→$904

Buy

-4.49%

Downside

Reiterated

12/10/25

McKesson price target raised to $904 from $861 at Deutsche BankMcKesson price target raised to $904 from $861 at Deutsche Bank

Unknown Analyst

William O'Neil

Not Ranked

William O'Neil

Buy

―

Initiated

10/17/25

McKesson (MCK) Initiated with a Buy at William O'Neil

Brian Tanquilut

Jefferies

$820→$900

Buy

-4.91%

Downside

Reiterated

10/13/25

McKesson's Strategic Initiatives and Growth Potential Justify Buy Rating and Increased Price Target

Michael Cherny

Leerink Partners

Buy

―

Reiterated

10/06/25

Leerink Partners Reaffirms Their Buy Rating on McKesson (MCK)

Daniel Grosslight

Citi

$820→$860

Buy

-9.14%

Downside

Reiterated

09/24/25

McKesson price target raised to $860 from $820 at CitiMcKesson price target raised to $860 from $820 at Citi

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Glen Santangelo

Barclays

$960→$1,050

Buy

10.94%

Upside

Reiterated

02/18/26

Barclays Keeps Their Buy Rating on McKesson (MCK)

Lisa Gill

J.P. Morgan

$983→$1,107

Buy

16.96%

Upside

Reiterated

02/10/26

McKesson price target raised to $1,107 from $983 at JPMorganMcKesson price target raised to $1,107 from $983 at JPMorgan

Steven Valiquette

Mizuho Securities

$885

Hold

-6.49%

Downside

Reiterated

02/10/26

Mizuho Securities Sticks to Its Hold Rating for McKesson (MCK)

Kevin Caliendo

UBS

$980→$1,012

Buy

6.92%

Upside

Reiterated

02/06/26

Analysts Offer Insights on Healthcare Companies: McKesson (NYSE: MCK) and Biogen (NASDAQ: BIIB)

Allen Lutz

Bank of America Securities

$950→$970

Buy

2.49%

Upside

Reiterated

02/05/26

Analysts Conflicted on These Healthcare Names: Phibro Animal Health (NASDAQ: PAHC), McKesson (NYSE: MCK) and Boston Scientific (NYSE: BSX)

Eric Coldwell

Robert W. Baird

$968→$974

Buy

2.91%

Upside

Reiterated

02/05/26

McKesson price target raised to $974 from $968 at BairdMcKesson price target raised to $974 from $968 at Baird

Charles Rhyee

TD Cowen

$1,000→$1,012

Buy

6.92%

Upside

Reiterated

02/05/26

Analysts Offer Insights on Healthcare Companies: McKesson (NYSE: MCK), GE Healthcare Technologies Inc (NASDAQ: GEHC) and Merck & Company (NYSE: MRK)

Stephen Baxter

Wells Fargo

$914→$925

Hold

-2.27%

Downside

Reiterated

02/05/26

Analysts Conflicted on These Healthcare Names: Eli Lilly & Co (NYSE: LLY), McKesson (NYSE: MCK) and Boston Scientific (NYSE: BSX)

Elizabeth Anderson CFA

Evercore ISI

$1,000

Buy

5.66%

Upside

Reiterated

02/05/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Prestige Consumer Healthcare (NYSE: PBH), McKesson (NYSE: MCK) and Bristol-Myers Squibb (NYSE: BMY)

Erin Wright

Morgan Stanley

$916→$966

Buy

2.06%

Upside

Reiterated

01/29/26

McKesson price target raised to $966 from $916 at Morgan StanleyMcKesson price target raised to $966 from $916 at Morgan Stanley

George Hill

Deutsche Bank

$861→$904

Buy

-4.49%

Downside

Reiterated

12/10/25

McKesson price target raised to $904 from $861 at Deutsche BankMcKesson price target raised to $904 from $861 at Deutsche Bank

Unknown Analyst

William O'Neil

Not Ranked

William O'Neil

Buy

―

Initiated

10/17/25

McKesson (MCK) Initiated with a Buy at William O'Neil

Brian Tanquilut

Jefferies

$820→$900

Buy

-4.91%

Downside

Reiterated

10/13/25

McKesson's Strategic Initiatives and Growth Potential Justify Buy Rating and Increased Price Target

Michael Cherny

Leerink Partners

Buy

―

Reiterated

10/06/25

Leerink Partners Reaffirms Their Buy Rating on McKesson (MCK)

Daniel Grosslight

Citi

$820→$860

Buy

-9.14%

Downside

Reiterated

09/24/25

McKesson price target raised to $860 from $820 at CitiMcKesson price target raised to $860 from $820 at Citi

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering McKesson

3 Months

xxx

Success Rate

17/21 ratings generated profit

Average Return

+7.19%

a xxx

rating ―

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 80.95% of your transactions generating a profit, with an average return of +7.19% per trade.

1 Year

Elizabeth Anderson CFAEvercore ISI

Success Rate

22/22 ratings generated profit

Average Return

+33.62%

a rating ―

Copying Elizabeth Anderson CFA's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +33.62% per trade.

2 Years

xxx

Success Rate

22/22 ratings generated profit

Average Return

+59.40%

a xxx

rating ―

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +59.40% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MCK Analyst Recommendation Trends

Rating

Oct 25

Nov 25

Dec 25

Jan 26

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, MCK has received 18 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. MCK average Analyst price target in the past 3 months is 982.27.

Each month's total comprises the sum of three months' worth of ratings.

MCK Financial Forecast

MCK Earnings Forecast

Next quarter’s earnings estimate for MCK is $11.56 with a range of $11.43 to $11.67. The previous quarter’s EPS was $9.34. MCK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year MCK has Performed in-line its overall industry.

MCK Sales Forecast

Next quarter’s sales forecast for MCK is $101.36B with a range of $98.91B to $104.92B. The previous quarter’s sales results were $106.16B. MCK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year MCK has Performed in-line its overall industry.

MCK Stock Forecast FAQ

What is MCK’s average 12-month price target, according to analysts?

Based on analyst ratings, Mckesson Corp.’s 12-month average price target is 982.27.

What is MCK’s upside potential, based on the analysts’ average price target?

Mckesson Corp. has 3.78% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is MCK a Buy, Sell or Hold?

Mckesson Corp. has a consensus rating of Strong Buy which is based on 9 buy ratings, 2 hold ratings and 0 sell ratings.

What is Mckesson Corp.’s price target?

The average price target for Mckesson Corp. is 982.27. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $1,107.00 ,the lowest forecast is $885.00. The average price target represents 3.78% Increase from the current price of $946.47.

What do analysts say about Mckesson Corp.?

Mckesson Corp.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.

How can I buy shares of MCK?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

McKesson (MCK) Stock Forecast & Price Target

MCK Analyst Ratings

MCK Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering McKesson

MCK Analyst Recommendation Trends

MCK Financial Forecast

MCK Earnings Forecast

MCK Sales Forecast

MCK Stock Forecast FAQ

Detailed List of Analyst Forecasts